We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.20 | 1.40 | 1.30 | 1.30 | 1.30 | 333,263 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
TIDMPYC
RNS Number : 7186V
Physiomics PLC
09 November 2017
9(th) November 2017
Physiomics plc
("Physiomics") or ("the Company")
Dispatch of Annual Report and Shareholder Circular
Dispatch of Documentation
Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has published and posted to shareholders
- its Annual Report for the financial year ended 30(th) June 2017 and - a circular in relation to its forthcoming Annual General Meeting
As already announced on the 16(th) October 2017, the Company's Annual General Meeting will be held at 10:00 a.m. on 13(th) December 2017 at the Company's registered office, The Magdalen Centre, Oxford Science Park, Robert Robinson Avenue, Oxford, OX4 4GA.
Resolutions To Be Proposed At The Annual General Meeting
Ordinary Resolutions:
1. To receive and adopt the financial statements and the report of the directors and auditors of the Company for the period ended 30 June 2017.
2. To re-appoint Dr Jim Millen as a Director of the Company
3. To confirm the appointment of Shipleys LLP as auditors of the Company to hold office until the conclusion of the next Annual General Meeting at which annual accounts of the Company are laid and to authorise the Directors to fix their remuneration
4. To authorise the directors to allot shares pursuant to section 551 of the Companies Act 2006.
Special Resolution
5. To disapply section 561 of the Companies Act 2006 in relation to the allotment in resolution (4) above.
EXPECTED TIMETABLE OF EVENTS
Latest time for receipt 10 a.m. on 11(th) December of Forms of Proxy: 2017 Annual General Meeting: 10 a.m. on 13(th) December 2017
ADDITIONAL STATISTICS
Number of Existing Ordinary Shares of 0.4p in issue at the date of this document 57,016,579 ------------------------------- -----------
A copy of the Circular containing further details of the resolutions as well as a copy of the Company's Annual Report will be made available on the Company's website.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad)
Katy Mitchell
+44 (0) 161 832 2174
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFLALILRIID
(END) Dow Jones Newswires
November 09, 2017 02:00 ET (07:00 GMT)
1 Year Physiomics Chart |
1 Month Physiomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions